| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC3188 |
| Trial ID | NCT05549921 |
| Disease | Childhood Soft Tissue Sarcoma |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | TAEST16001 |
| HLA | HLA-A*02:01 |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | TAEST16001 in Patients With Soft Tissue Sarcoma With Positive NY-ESO-1 Expression (Genotype: HLA-A*02:01): an Multi-center, Open-label and Single Arm Phase II Study |
| Year | 2022 |
| Country | China |
| Company sponsor | Sun Yat-sen University |
| Other ID(s) | TAEST16001 Phase II |
| Cohort 1 | |||||||||
|
|||||||||